News from cepheid A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Feb 19, 2013, 04:05 ET Cepheid And Oregon Health & Science University Collaborate To Develop Oncology Assays For GeneXpert® System

Cepheid (Nasdaq: CPHD) and the Knight Cancer Institute at Oregon Health & Science University (OHSU) today announced a collaboration to develop a menu ...


Feb 14, 2013, 04:05 ET Cepheid Announces Board of Directors Changes

Cepheid (Nasdaq: CPHD) today announced that its Board of Directors has elected John Bishop as Chairman of the Board of Directors and named Cristina...


Jan 31, 2013, 04:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Jan 24, 2013, 04:05 ET Cepheid Reports Fourth Quarter And Full Year 2012 Results

Cepheid (Nasdaq: CPHD) today reported revenue for the fourth quarter of 2012 of $92.4 million. Net income was $5.6 million, or $0.08 per share, which ...


Jan 15, 2013, 07:00 ET Cepheid Announces Chlamydia and N. gonorrhoeae Test Categorized 'Moderate Complexity' by FDA

Cepheid (NASDAQ: CPHD) today announced the U.S. Food & Drug Administration (FDA) has categorized Cepheid's Xpert® CT/NG test as 'Moderate Complexity' ...


Jan 08, 2013, 08:30 ET Cepheid Announces Update On Xpert® Test Availability

Ahead of its presentation at the JP Morgan Healthcare Conference in San Francisco later today, Cepheid (Nasdaq: CPHD) this morning shared an update...


Dec 27, 2012, 04:10 ET Cepheid Receives FDA Clearance for Xpert CT/NG, Delivering Rapid Detection and Differentiation of Chlamydia and N. gonorrhoeae

Cepheid (NASDAQ: CPHD) today announced that it has received clearance from the U.S. Food & Drug Administration (FDA) to market Xpert® CT/NG. Running...


Nov 28, 2012, 04:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Nov 05, 2012, 04:05 ET Cepheid Announces Executive Vice President Emerging Markets

Cepheid (Nasdaq: CPHD) today announced that Philippe Jacon, currently CEO of the Foundation of Innovative New Diagnostics (FIND), will join Cepheid...


Oct 25, 2012, 04:15 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Oct 18, 2012, 04:05 ET Cepheid Reports 2012 Third Quarter Results

Cepheid (Nasdaq: CPHD) today reported revenues for the third quarter of 2012 of $80.5 million, representing growth of 15% from $70.2 million for the...


Sep 26, 2012, 04:05 ET Cepheid Announces Preliminary 2012 Third Quarter Revenue Results

Cepheid (Nasdaq: CPHD) today announced preliminary revenue results for the 2012 Third Quarter, ending September 30, 2012. Based on current...


Aug 09, 2012, 04:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following conferences, and invited investors to participate via...


Aug 06, 2012, 04:05 ET Cepheid Announces First Phase Of Xpert MTB/RIF Buy-Down For High Burden Developing Countries

Cepheid (Nasdaq: CPHD) today announced the first in a series of agreements with the Bill & Melinda Gates Foundation, the United States President's...


Jul 25, 2012, 07:00 ET Cepheid Announces Release of Updated Xpert BCR-ABL Monitor Test

Cepheid (NASDAQ: CPHD) today announced the release of an updated Xpert® BCR-ABL Monitor test, now incorporating lot-specific standardization using...


Jul 19, 2012, 04:05 ET Cepheid Reports 2012 Second Quarter Results

Cepheid (Nasdaq: CPHD) today reported revenues for the second quarter of 2012 of $81.0 million, representing growth of 21% from $67.0 million for the ...


Jul 09, 2012, 04:05 ET Cepheid Schedules 2012 Second Quarter Financial Results Announcement And Webcast

Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2012 second quarter on Thursday, July 19, 2012, after the close...


Jun 14, 2012, 11:31 ET Cepheid Welcomes UNITAID Commitment To Broaden Access To "Ground-Breaking" Xpert® MTB/RIF

Cepheid (Nasdaq: CPHD) today welcomed UNITAID's announcement that it has approved funding of $30 million to scale up access to the "ground-breaking"...


May 31, 2012, 04:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to...


May 24, 2012, 07:00 ET Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay

Cepheid (NASDAQ: CPHD) today announced that the U.S. Food & Drug Administration (FDA) has cleared its GeneXpert® Infinity-80 System, a...


May 23, 2012, 07:00 ET Cepheid Announces European Release of Xpert CT/NG and Xpert CT, Delivering Rapid Detection and Differentiation of Chlamydia and Gonorrhoeae

Cepheid (NASDAQ: CPHD) today announced that both Xpert® CT/NG and Xpert® CT have received CE marking, with shipments expected to begin immediately....


Apr 26, 2012, 04:05 ET Cepheid to Webcast Upcoming Financial Presentations

Cepheid (NASDAQ: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to...


Apr 19, 2012, 04:05 ET Cepheid Reports 2012 First Quarter Results

Cepheid (Nasdaq: CPHD) today reported revenues for the first quarter of 2012 of $77.3 million, representing growth of 28% from $60.2 million for the...


Apr 05, 2012, 04:05 ET Cepheid Schedules 2012 First Quarter Financial Results Announcement and Webcast

Cepheid (Nasdaq: CPHD) today announced that it will report financial results for its 2012 first quarter on Thursday, April 19, 2012, after the close...


Mar 20, 2012, 07:00 ET Cepheid Receives Grant to Develop Sample Processing and Amplification Methods for Detection of Bloodstream Bacteria

Cepheid (NASDAQ: CPHD) today announced that, together with the University of Medicine and Dentistry of New Jersey (UMDNJ), it has received a grant...